Bud BilanichSuccess Coach
Daniel SontupeMarket Access
Suma Ramadas, PhDMedical Affairs
David LinetskyPoint-of-Care Marketing
Amy GilesIncreasing Engagement
Frank BurrellScientific Storytelling
Paul TheisenPatient Acquisition
Stacey GandlerBrand Nourishment
Matt TurnerPatient Affordability
Brenda SnowAuthentic Patient Voice
Pat PurcellMeeting Engagement
Matthew DurhamOmnidynamic Marketing
Liz KaneImpactful Strategy
Joey CohenMedication Adherence
Adds 177Lu-PSMA-617, a potential first-in-class radioligand therapy in Phase III development for metastatic castration-resistant ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email